Engineers transfer a 350-volt battery pack to be put in in a Fedex Corp. Express General Motors Co. (GM) van on the VIA Motors Inc. facility in Orem, Utah, U.S. on Monday, Feb. 17, 2014.
George Frey | Bloomberg | Getty Images
Here are the shares making headlines after the bell.
FedEx — Shares of the delivery firm rose more than 3% after FedEx issued upbeat steering for its full fiscal 12 months, projecting an increase in adjusted earnings. FedEx reported blended outcomes for its just lately accomplished fiscal fourth quarter, with $6.87 in adjusted earnings per share on $24.39 billion of income. Analysts surveyed by Refinitiv had been anticipating $6.86 in earnings per share on $24.56 billion of income.
Sarepta Therapeutics — The biopharma inventory dropped more than 5% in prolonged buying and selling after the FDA positioned a medical maintain on Sarepta’s therapy for Duchenne muscular dystrophy. Sarepta mentioned there was a “serious adverse event” in one of many research for the therapy.
Smith & Wesson Brands — Shares of the firearms producer dipped about 2% after Smith & Wesson’s fiscal fourth-quarter report confirmed a 12 months over 12 months decline in income and gross margin. The firm, which has a market cap of roughly $650 million, hiked its quarterly divided to 10 cents per share from 8 cents.
